EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
63 hedge funds and large institutions have $334M invested in Eidos Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
63
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.76M | |
| 3 | +$6.57M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.34M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.1M |
Top Sellers
| 1 | -$5.94M | |
| 2 | -$965K | |
| 3 | -$716K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$536K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$384K |